{
  "docId": "019dd923-5ca1-7489-b638-195715167efa",
  "docSlug": "c4a00c854103dba5",
  "documentTitle": "Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies",
  "authorId": "LEK",
  "authorName": "L.E.K.",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 21,
  "pageCount": 31,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "agenda",
  "function": "front_matter",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-195715167efa/21",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-195715167efa",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-195715167efa.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-195715167efa#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.361,
        "w": 0.308,
        "x": 0.038,
        "y": 0.225
      },
      "kind": "list",
      "text": "Summary\nCustomer priorities and preference\nImpact from NRDL and VBP\nDigitalization trends\nHospital financial outlook",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3182fed-caad-4ec1-9935-c80c94204ebe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.075,
        "x": 0.038,
        "y": 0.144
      },
      "kind": "title",
      "text": "Agenda",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9dcbfcaa-b278-42b5-9fac-f719d843e976",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 26,
      "from": 21,
      "beatId": "b74685bb-b894-4850-be6d-3054b1097402",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The industry trends and pain points slides discuss the implications and next steps for pharma companies.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 26,
      "from": 21,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "43ba1106-f7a3-42c7-bc61-bc49932818ab",
      "evidence": "The industry trends and pain points slides discuss the potential consequences of inaction.",
      "position": 1,
      "objective": "What are the implications of not adapting to the evolving priorities of hospitals in China?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}